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Abstract
We recently identified 15 genes encoding putative surface proteins with features of MSCRAMMs
and/or pili in the Enterococcus faecium TX16 (DO) genome, including four predicted pilus-
encoding gene clusters; we also demonstrated that one of these, ebpABCfm, is transcribed as an
operon, that its putative major pilus subunit, EbpCfm (also called PilB), is polymerized into high
molecular weight complexes, and that it is enriched among clinical E. faecium isolates. Here, we
created a deletion of the ebpABCfm operon in an endocarditis-derived E. faecium strain (TX82)
and showed, by a combination of whole-cell ELISA, flow cytometry, immunoblot and
immunogold electron microscopy, that this deletion abolished EbpCfm expression and eliminated
EbpCfm-containing pili from the cell surface. However, transcription of the downstream sortase,
bpsfm, was not affected. Importantly, the ebpABCfm deletion resulted in significantly reduced
biofilm formation (p < 0.0001) and initial adherence (p < 0.0001) versus the wild-type; both were
restored by complementing ebpABCfm in trans, which also restored cell surface expression of
EbpCfm and pilus production. Furthermore, the deletion mutant was significantly attenuated in two
independent mixed infection mouse urinary tract experiments, i.e., outnumbered by the wild-type
in kidneys (p = 0.0003 and < 0.0001, respectively) and urinary bladders (p = 0.0003 and = 0.002).
In conclusion, we have shown that the ebpABCfm locus encodes pili on the E. faecium TX82 cell
surface and provide the first evidence that pili of this emerging pathogen are important for its
ability to form biofilm and to cause infection in an ascending UTI model.
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Introduction
Enterococci are commensal inhabitants of the human intestinal tract and also long known as
an important cause of nosocomial infections, such as catheter-associated urinary tract
infections (UTI) (ranking second among all organisms recovered from this site),1-3 surgical
site infections, bloodstream infections and endocarditis, among others.4-6 During the last 15
years, a major epidemiological shift has been noted in the incidence of E. faecium in both
US and European hospitals, with the ratio of E. faecium to Enterococcus faecalis gradually
changing in favor of E. faecium, from 1:9 in the past to approximately 4:6 in a recent CDC
study.1, 7-9
In addition to attachment to and colonization of host tissue surfaces, the ability to form
biofilm is considered potentially important for enterococcal infections.10-13 Supporting this,
our previous evaluation of 163 E. faecalis isolates indicated that strains derived from
endocarditis form biofilm significantly more often than non-endocarditis isolates.14 We
recently demonstrated multimeric proteinaceous surface appendages called pili (also known
as fimbriae) on the surface of E. faecalis cells and showed, by mutagenesis, that these pili
are involved in its ability to form biofilm on an abiotic surface and cause infection in
experimental models of endocarditis and ascending UTI; formation of biofilm is generally
considered as an important characteristic for both infections.10-12 Similar to the recently
characterized pili of other gram-positive pathogens, such as corynebacteria and streptococci,
15-17 pili of E. faecalis are encoded by a three-gene locus (ebp), encoding structural pilus
subunit proteins (also known as pilins). An adjacent gene (bps in E. faecalis), encodes a
pilus-dedicated class C sortase, which tethers individual pilins to form an elongated pilus.15,
17, 18 So far, multiple other genes or gene clusters have also been reported to affect biofilm
formation of E. faecalis isolates,14, 19-26 thus highlighting the complexity and
multicomponent nature of this phenotype. However, much less is known about E. faecium.
Heikens et al.27 showed that Esp is involved in biofilm formation of a clinical E. faecium
blood isolate (E1162) and, recently, sgrA was also implicated as a potential additional factor
for biofilm formation of the same isolate.28 However, insertional mutagenesis of the highly
homologous esp gene of E. faecalis resulted in variable effects among different strains,
ranging from complete loss of biofilm formation to no effect.26 Furthermore, our recent
analysis of biofilm formation by E. faecium isolates of diverse origin showed efficient
biofilm production in the absence of esp by many of the isolates (S. Almohamad, KVS,
SRN, BEM; manuscript in preparation). Hence, we considered it likely that other factor(s)
also contribute to this phenotype in E. faecium.
In silico searches of the draft genome sequence of E. faecium TX16 by our group and by
Hendrickx et al.29, 30 recently led to the identification of 22 putative LPXTG-family cell
wall anchored proteins, which we named Fms (E. faecium surface protein). Among these are
four gene clusters, each located with an adjacent class C sortase, and predicted to encode
four distinct types of pili. We demonstrated that one of these gene clusters, ebpABCfm
(fms1-5-9), is transcribed as an operon and that its predicted major pilus subunit protein,
EbpCfm (EbpAfm and EbpBfm are putative accessory pilus subunits), forms high molecular
weight (HMW) complexes in E. faecium, characteristic of gram-positive pili. Recently,
Hendrickx et al.31 showed pilus-like structures stained by an antiserum against PilB
(EbpCfm) on cells of an E. faecium wound isolate.
In this study, we have created a deletion of the pilus-encoding ebpABCfm operon in E.
faecium TX82, complemented the deletion in trans, and characterized production of EbpCfm
and polymerized pili on the E. faecium cell surface by these constructs. We then evaluated
the effect of the ebpABCfm deletion on the ability of E. faecium to form biofilm in vitro and
to cause UTI in a mouse model.
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Results
Creation of a deletion of the pilus-encoding ebpABCfm cluster of E. faecium TX82 and its
effect on the activity of the downstream sortase gene, bpsfm
We selected the endocarditis-derived E. faecium strain TX82 for deletion of all three genes
of the pilus-encoding ebpABCfm operon, ebpAfm, ebpBfm and ebpCfm, using homologous
recombination with allelic replacement by a cat gene; our previous studies showed that this
gene cluster (Fig. 1A) is present in and expressed under in vitro growth conditions by
TX82.30 Comparison of growth characteristics of the deletion mutant (TX82ΔebpABCfm)
with its isogenic parental strain (TX82) showed no significant differences in their growth
kinetics or viability when grown in broth cultures of either BHI or TSBG (Supplemental Fig.
1).
Our previous northern analysis and reverse transcriptase (RT)-PCR data demonstrated that
the ~ 7 kb ebpABCfm transcript does not include the downstream class C sortase gene, bpsfm,
which is separated from the operon by a predicted strong transcriptional terminator and,
therefore, likely to be transcribed independently.30 We next performed RT-PCR to confirm
that the ebpABCfm deletion did not disrupt the expression of bpsfm. Using a primer pair
designed to amplify a 5’ upstream border region of ebpAfm and another primer pair for an
internal segment of ebpAfm, no transcription was detected from the ΔebpABCfm deletion
mutant, while amplification products of the expected sizes were observed for both primer
pairs from the wild-type (WT) mRNA, as anticipated (Fig. 1). However, all three primer
pairs spanning different intragenic regions of bpsfm detected its transcription in the
ΔebpABCfm deletion mutant at apparently WT levels, indicating lack of a downstream polar
effect on bpsfm expression by the deletion of the ΔebpABCfm genes.
Cell surface expression of EbpCfm by WT TX82 and its isogenic ebpABCfm deletion mutant
and complementation derivatives
In an effort to find optimal conditions for the expression of ebpABCfm-encoded pili for
subsequent studies (see below), we analyzed the effect of different growth conditions and
growth stages on EbpCfm expression by whole-cell ELISA, using a purified EbpCfm-specific
antibody.30 With WT TX82 cells harvested from lag (1 h), mid exponential (6 h) and late
stationary (16 h) stages (gentamicin was added for pAT392 constructs), no significant
differences in surface expression levels of EbpCfm were observed between growth in either
BHI or TSBG broth (Fig. 2A). However, more than two-fold higher EbpCfm expression was
detected at mid-exponential and late stationary phases versus the lag phase in both media,
similar to a previous report with an E. faecium wound isolate, E1165, grown in BHI.31
Comparably high EbpCfm expression was also observed by cells grown on BHI agar. Thus,
these results indicate that EbpCfm is readily expressed under multiple in vitro conditions and
throughout the growth cycle.
As expected, the ΔebpABCfm deletion abolished EbpCfm production. As seen in Fig. 2A,
complementation of the ebpABCfm mutant led to EbpCfm expression in whole-cell ELISA at
a consistently higher level in all conditions tested versus the WT, while no expression was
detected by an isogenic control with the empty plasmid. Furthermore, quantification of
EbpCfm surface expression by flow cytometry showed a slightly increased percentage of the
complemented deletion mutant expressing EbpCfm (grown in the presence of gentamicin)
versus WT (47% versus 40%) (Fig. 2B). These cells also showed higher fluorescence
intensities (mean fluorescence intensities 41 versus 22, median 51 versus 29, respectively),
suggesting that more EbpCfm molecules were expressed on the cell surface. Neither the
ΔebpABCfm deletion mutant nor its complementation derivative with the empty vector
showed surface expression of EbpCfm. Similarly, the multiple HMW bands seen in a
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western blot analysis of mutanolysin cell wall extracts of TX8230 were not produced by the
ΔebpABCfm deletion mutant (Fig. 2C). The complemented mutant showed a similar pattern
of HMW bands as the WT, although with a higher proportion of lower molecular weight
polymers and a band corresponding to the size of monomeric EbpCfm. These results suggest
the possibility that the constitutively expressed EbpCfm in the complemented deletion
mutant may overload the polymerization capacity of the native sortase, leading to greater
amounts of unpolymerized and partially polymerized subunits. Nonetheless, they confirm
that plasmid-encoded ebpCfm is polymerized into a ladder-like pattern of HMW complexes
characteristic of pilus structures of gram-positive pili.
Analysis of pilus structures on TX82 cells
Using high-resolution transmission electron microscopy (TEM) and negative staining, we
observed filamentous structures resembling pili attached to the surface of TX82 cells
collected from several growth conditions (BHI and TSBG broth, BHI and blood agar plates)
(Fig. 3). Furthermore, these structures were specifically recognized by the anti-EbpCfm
antibody using immunogold staining, while no staining of pili was seen by purified pre-
immune antibodies from the same animal or purified antibodies against Fms13 and Fms16
(unpublished data), two predicted other pilus major subunits of E. faecium TX16.30
Although pleomorphic, these pili morphologically resembled the recently observed pili of
another E. faecium isolate, E1165, which represents a wound isolate of European origin.31
The gold particles were found evenly scattered along the shaft of the pilus, supporting the
predicted role of EbpCfm as a major pilus subunit. Approximately 40% of TX82 cells grown
in BHI broth were seen to express these pili, with no obvious differences observed in the
other growth conditions. Of note, some of the Ebp pili appeared to be attached to one or
more neighboring cells, suggesting the possibility of involvement in cell-cell interactions
(Fig. 3, panels C and I). As anticipated, the EbpCfm-specific antibody did not detect pili on
the surface of the ebpABCfm mutant, nor on the mutant with empty vector, while
complementation in trans restored pilus production of the ebpABCfm mutant.
Effect of the ebpABCfm deletion on biofilm formation
As seen in Fig. 4A, deletion of ebpABCfm reduced biofilm formation by 75% versus the WT
(p < 0.0001). For testing the complementation constructs, we initially performed the assay
using the same conditions, i.e., without the addition of gentamicin, due to the effect some
antibiotics may have on biofilm formation.18, 32 While a small but significant enhancement
was observed by the complemented mutant over the empty vector control (p < 0.0001), its
biofilm production was only 38% of WT level. Moreover, WT TX82 supplemented in trans
with ebpABCfm (TX82 (pAT392∷ebpABCfm)), thus carrying both a chromosomal and
plasmid-encoded copy of ebpABCfm, showed reduced biofilm formation compared to TX82
or TX82 with the empty complementation vector (TX82 (pAT392)).
Because only partial restoration of biofilm formation was observed by the complemented
mutant, we performed further assays in two additional conditions, i) by including gentamicin
in the overnight culture (16 h) used as the biofilm inoculum and ii) by including gentamicin
for both growth of the biofilm inoculum and in the assay incubations (24 h) in microtiter
trays. Adding gentamicin to the inoculum significantly increased biofilm activity by the
complemented mutant versus the vector control (p < 0.0001, Fig. 4B), and still higher
enhancement was observed when gentamicin selective pressure was maintained throughout
the experiment (> 2.5-fold increase, p < 0.0001, Fig. 4C). The supplemented WT, TX82
(pAT392∷ebpABCfm), showed a similar pattern in both conditions as without gentamicin,
with the additional copy of ebpABCfm leading to reduced biofilm production versus TX82
(pAT392) (Fig. 4B and C). However, it is notable that the overall level of biofilm formation
was reduced when gentamicin was present throughout the biofilm assay. In this condition,
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the complemented ebpABCfm mutant (TX82ΔebpABCfm (pAT392∷ebpABCfm)) showed
significantly higher biofilm formation than TX82 (pAT392) (p < 0.0001). The in trans
complementation by plasmid-encoded ebpABCfm confirms the role of the ebpABCfm operon
in biofilm and shows that this construct leads to overexpression of the biofilm phenotype
when antibiotic selection pressure is maintained continuously.
Since the above results pointed to potential plasmid instability, we assessed the amount of
plasmid loss in each of the three biofilm conditions. Without gentamicin selection pressure,
90% of cells on average (ranging between 82 and 100% in three independent assays) had
lost the complementing plasmid (pAT392∷ebpABCfm) at 24 h, while including gentamicin in
the inoculum increased its stability slightly (plasmid loss 81%, range 69-94%) and
continuous presence of gentamicin resulted in greatly reduced plasmid loss (13%, range
8-16%). In contrast, pAT392 was relatively stable even in the absence of gentamicin
throughout the assay (plasmid loss 7%, range 7-8%). Although the specific reason for the
more severe instability of pAT392∷ebpABCfm versus pAT392 in the absence of gentamicin
is not known, it may be related to the observed overexpression of structural pilus
components by the complemented deletion mutant (see above) which, by utilizing a portion
of the cells metabolic resources, could give an advantage to cells that have lost the plasmid.
Evaluation of primary attachment showed efficient binding of TX82 cells to the polystyrene
surface (Fig. 5A). The ebpABCfm deletion nearly abolished (p < 0.0001) this initial
adherence, while complementation, either with cells grown in the absence or presence of
gentamicin, restored the adherence phenotype (34-fold and 10-fold increase versus the
vector control, respectively; p < 0.0001 for both; Fig. 5A and B). The lack of noticeable
effect of plasmid instability on the adherence of the complemented mutant may be caused by
the shorter incubation of cultures without gentamicin in this assay, oversaturation of the
binding surface by the relatively high amount of added bacteria and/or “entrapment” of non-
piliated cells by cells retaining the complementing plasmid. Adherence of the complemented
deletion mutant was significantly higher than TX82 (pAT392) (p < 0.0001), consistent with
the overexpression of EbpCfm by this construct (Fig. 2) and the biofilm formation data
above. The additional copy of ebpABCfm in TX82 (pAT392∷ebpABCfm) resulted in reduced
initial adherence versus TX82 (pAT392) when cells were grown with gentamicin, similar to
biofilm formation; the reason for this remains to be determined.
Importance of the ebpABCfm locus for UTI in a mouse model
To test whether deleting the ebpABCfm locus has an effect on E. faecium virulence, we used
a mixed infection assay and a mouse model of UTI, as previously described.33, 34 In brief,
an equal suspension of TX82 and the ΔebpABCfm mutant (2.8 × 106 CFU/mouse) was
inoculated into 10 mice using catheters and, at 48 h, the mean (geometric) CFUs of total
bacteria (WT plus mutant) recovered from kidneys and bladders were 1.2×105/gm and
6.7×104/gm, respectively. The mean percentages of total CFUs recovered from kidneys were
76.5 for TX82 versus 23.5 for the deletion mutant and, in bladders, 88.3 and 11.7,
respectively, showing a clear advantage of TX82 versus the deletion mutant and a
significant difference between TX82 in the inoculum and the kidneys and bladders (p =
0.0003 for both). In a second experiment, we used an inoculum 10-fold higher for the
deletion mutant (2.2 × 107 CFU/mouse) than the WT (2.2 × 106 CFU/mouse). Bacteria were
recovered from the kidneys of all 7 mice inoculated, and the bladders of 4 of these mice,
while 3 bladders were not infected. Total CFUs (geometric means of WT + mutant)
recovered from kidneys were 1.3×104/gm and from infected bladders, 4.9×104/gm. Again,
significantly higher numbers of WT TX82 were recovered than the mutant (mean percentage
81.9 versus 18.1 in infected kidneys, and 86.2 versus 13.8 in infected bladders, respectively)
in both kidneys (p < 0.0001, Fig. 6A) and in bladders (p = 0.002, Fig. 6B). The mean
virulence indices18, 35, 36 of the ebpABCfm mutant versus the WT were 0.307 for kidneys
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and 0.133 for bladders for the first experiment (with WT to mutant ratio of 1:1) and 0.022
and 0.016 (with WT to mutant ratio of 1:10) for the second experiment, respectively,
indicating that the ebpABCfm locus contributes significantly to this infection.
Discussion
Although usually a harmless resident of the human intestinal tract, some strains of E.
faecium, particularly those belonging to the recently emerged CC17 genogroup,9, 37 have
shown remarkable adaptability to nosocomial environments and have increasingly
developed into opportunistic pathogens able to cause a wide variety of healthcare-associated
(HA) infections in humans.4-6 In addition to the acquisition of resistance among nosocomial
E. faecium isolates to multiple, commonly used antibiotics, such as ampicillin, vancomycin
and aminoglycosides, recent epidemiological studies have suggested that these isolates have
also evolved or acquired other traits that have contributed to their increased prevalence. For
instance, HA isolates more often carry genes (e.g., hyl, encoding a hyaluronidase-like
glycoside hydrolase,38 esp, encoding an enterococcal surface protein39 or a functional copy
of a gene (acm, encoding a collagen-binding adhesin)40, 41 associated with virulence.
Furthermore, our recent analysis of 433 E. faecium isolates from diverse clinical and non-
clinical sources indicated that the presence of most of the 15 fms genes, which encode
characterized or putative MSCRAMM and/or pilus proteins including the ebpABCfm gene
cluster of this study, are found more often in clinical isolates, including CC1742, 43 and,
thus, may have contributed to the emergence of E. faecium isolates with increased survival,
colonization and/or ability to cause HA infections.
Here, we have analyzed cell surface expression of EbpCfm, the putative major pilus subunit
protein of the ebpABCfm operon, and EbpCfm-containing pili by an endocarditis-derived E.
faecium isolate TX82, its isogenic ebpABCfm deletion and complementation derivatives. We
found that deletion of ebpABCfm eliminated Ebp pili from the cell surface of TX82 and led
to significant attenuation in its ability to adhere to polystyrene and form biofilm, and cause
infection in a murine model of ascending UTI. Complementation of the deleted ebpABCfm in
trans restored surface expression EbpCfm and its polymerization into HMW complexes and
also resulted in pilus production on the cell surface. These pili were variable in length and
thickness, and generally similar in appearance to those seen on WT cells, with anti-EbpCfm
antibodies evenly scattered along the pilus shaft. Thus, our data unambiguously show that
the ebpABCfm locus codes for pili observed on the TX82 cell surface and that
complementation of the ebpABCfm deletion in trans leads to efficient pilus synthesis by the
native sortase.
The proposed link between biofilm formation and various enterococcal infections, such as
UTI, is that bacteria may be less effected by host immune defenses and therapeutic
antibiotics and, thus, seems relevant to the pathogenesis of the increasingly antibiotic-
resistant enterococci.12, 44 Our recent assessment of the prevalence among a large collection
of E. faecium isolates of their ability to form biofilm in vitro identified TX82 as an efficient
biofilm producer (S. Almohamad, KVS, SRN, BEM; manuscript in preparation). The strong
reduction in its biofilm forming ability (75% versus WT) by the ebpABCfm deletion
indicates that Ebp pili are an important factor contributing to the biofilm phenotype of this
isolate. Our data also showed that this mutant has a clear defect (96% reduction versus WT)
in its initial adherence to the polystyrene surface, providing at least one explanation for the
attenuation of the biofilm phenotype. TX82 does not carry the esp gene (unpublished data),
previously shown to affect the biofilm phenotype of another E. faecium isolate, E1162.27
Although lower biofilm densities by E1162 were observed by Heikens and colleagues,27 in
our hands, this strain’s biofilm and the reduction by its esp mutant were comparable to what
we observed for TX82 (lacking esp) and its ebpfm mutant, respectively (Supplemental Figure
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2); this is consistent with observations for other bacteria that various factors can contribute
differently to biofilm formation in different strains. A larger number of isolates needs to be
tested to assess the overall impact of these two genes on the biofilm phenotype of E.
faecium.
Since antibiotics may affect the biofilm phenotype, we considered it preferable to perform
biofilm assays without added antibiotics; indeed, we subsequently observed in this study a
decrease in overall biofilm densities in the presence of gentamicin. However, we found the
complementing plasmid (pAT392∷ebpABCfm) to be highly unstable in the absence of
gentamicin (~10% of cells retained the plasmid), which is likely the cause for only partial,
although statistically significant, restoration of biofilm formation in the absence of
gentamicin. In contrast, in the presence of gentamicin, pAT392∷ebpABCfm was relatively
stably maintained (retained by ~87% of cells), and this led to clearly increased enhancement
of biofilm formation, reaching 120% of the level observed with TX82 (pAT392), also grown
in gentamicin. Complementation also restored initial adherence and resulted in a similar
increase relative to TX82 (pAT392) (135% for cells grown without, 148% with,
gentamicin). These observations are consistent with the overproduction of EbpCfm on the
cell surface of the complemented deletion mutant observed by both flow cytometry and
whole-cell ELISA under various in vitro growth conditions, including TSBG, the biofilm
culture medium. While our data demonstrated the importance of the ebpABCfm locus for the
initial adherence stage of biofilm formation, its specific function in subsequent biofilm
maturation remains unknown. The Ebp pili could mediate physical interactions and
adherence between individual cells, thus facilitating the accumulation of a multicellular
biofilm network. Supporting this hypothesis, our immuno-EM analysis showed, in some of
the fields, two or more neighboring cells apparently connected by Ebp pili, as was also
previously seen with the biofilm-associated pili of E. faecalis. 18 Another possibility is that
the polymerized pilus material could participate in the buildup of the biofilm matrix,
surrounding and embedding bacterial cells, as has been proposed for extracellular
polysaccharides14, 45, 46 and DNA.24, 25, 47-49
Although commonly isolated from nosocomial UTIs, little is known about the factors
important for the attachment and colonization of E. faecium at this site. Recently, Leendertse
et al.50 showed that Esp is involved in transient aggravation of experimental E. faecium UTI.
Since several enterococcal infections in humans, including UTI, are thought to involve
biofilm formation in the host, we tested the ebpABCfm deletion mutant in a mouse UTI
model using a competition assay, which has been previously established as a UTI model for
E. faecalis.33, 34, 51 With a mixed inoculum containing equal numbers of CFUs of WT
TX82 and the ebpABCfm mutant, deletion of ebpABCfm resulted in clear attenuation in the
ability of TX82 to cause infection. That is, WT was recovered in significantly higher
numbers of CFU’s than deletion mutant in both kidneys (3.3-fold) and bladders (7.5-fold).
The severe instability of pAT392∷ebpABCfm, similar to the previous observation of another
complementation vector in E. faecium,52 prevented its inclusion in the UTI model.
Nevertheless, a 10-fold overdose of the mutant relative to WT in the inoculum resulted in a
similar outnumbering of WT over the mutant in both kidneys (4.5-fold) and bladders (6.2-
fold), thus confirming the significant attenuation of the ebpABCfm mutant. Interestingly, the
higher number of colonized kidneys versus bladders in some mice resembles reports with E.
faecalis33, 53, 54 and could reflect similar tropism of both organisms for kidneys.34
In summary, we have shown that the ebpABCfm-encoded pili of E. faecium are important for
both the biofilm phenotype and colonization of kidneys and bladders in an experimental UTI
model. The recent protective active and/or passive immunization in animal models using
pilus subunits from streptococci,55-57 suggests that pili of gram-positive cocci could be
useful targets for alternative preventive or therapeutic approaches. In this respect, the
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presence of the ebpABCfm locus in >95% of clinical E. faecium isolates,42 its similarity to
the pilus-encoding genes of E. faecalis pili and their comparable effects on biofilm
formation and UTI in both organisms, make this locus particularly attractive for antibacterial
strategies against enterococcal infections.
Materials and Methods
Bacterial strains, plasmids, and growth conditions
E. faecium and Escherichia coli strains as well as plasmids used in this study are listed in
Table 1. Plasmid constructs were given pTEX numbers and their host strains corresponding
TX numbers. E. faecium strains were routinely grown in/on brain heart infusion (BHI)
(Difco Laboratories, Detroit, MI) broth/agar or, for some experiments (see below), in tryptic
soy broth supplemented with 0.25% glucose (TSBG) or on trypticase soy agar supplemented
with 5% sheep blood (Becton Dickinson, Franklin Lakes, NJ), and E. coli in Luria-Bertani
media (Difco Laboratories) at 37°C. With E. faecium TX82, gentamicin (Sigma Chemical
Co., St. Louis, MO) was used at 125 μg/mL (150 μg/mL for selection of transformants) and
chloramphenicol at 10 μg/mL and, with E. coli, gentamicin was used at 25 μg/mL.
General techniques
Chromosomal DNA from E. faecium TX82 was isolated by the hexadecyltrimethyl
ammonium bromide method.58 Pulsed-field gel electrophoresis was performed as described
earlier.59, 60
Construction of an ebpABCfm deletion mutant and its complementation
The ebpABCfm region of E. faecium TX82 was deleted by allelic replacement, as described
previously.61 Briefly, upstream (817 bp) and downstream fragments (803 bp) flanking the
ebpABCfm region were amplified using primers listed in Supplemental Table 1, and ligated
into pTEX5501ts, on either side of the cat gene, followed by transformation into E. coli
DH5α. The resulting plasmid, pTEX5644 (Table 1), was confirmed by sequencing and
electroporated into E. faecium TX82. Single-crossover integrants (TX82∷pTEX5644) were
selected on BHI plates supplemented with gentamicin and chloramphenicol. Transformants
were cultured consecutively six times, then plated on non-selective media at 37°C, and
resulting colonies scored for sensitivity to gentamicin and resistance to chloramphenicol, to
select for plasmid excision (conferring susceptibility to gentamicin) by double-crossover
recombination. In the resulting ebpABCfm deletion derivative (TX5645), the deleted region,
replaced by the cat gene, begins at and includes the ATG start codon of the ebpAfm coding
sequence and extends to 93 bp upstream of the ebpCfm TAG stop codon; the 3′ end of
ebpCfm was left intact to avoid disrupting the activity of the downstream sortase gene bpsfm.
The deletion site in TX5645 was confirmed by PCR, sequencing and pulsed-field gel
electrophoresis.
For complementation, the complete ebpABCfm region, including its own RBS, was amplified
from genomic DNA of TX82 (see Supplemental Table 1 for primers), cloned under the
constitutive P2 promoter in pAT39262 and confirmed by sequencing. This plasmid,
pTEX5665, was then electroporated into the ebpABCfm deletion mutant (TX5645).
Growth curve
Pre-warmed BHI or TSBG broth was inoculated with an overnight culture at an initial
optical density of 0.05 or 0.1 at 600 nm (OD600nm). The culture was then grown at 37°C
with shaking, and samples were taken at regular intervals to measure their OD600nm and, at
0, 3, 5, 7 and 24 h, for determining their CFU counts on BHI agar.
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Reverse transcriptase (RT)-PCR
Total RNA isolation from TX82 and TX5645 (TX82ΔebpABCfm), grown in BHI to mid-
exponential phase, and RT-PCR (see Supplemental Table 1 for primers) was performed as
described previously.30 A 509-bp fragment of the gyrA (encoding gyrase A) gene was
amplified as an internal control of the PCR reaction and reactions without reverse
transcriptase were performed to confirm the lack of DNA contamination in the RNA
preparation.
Whole-cell ELISA and flow cytometry
Whole-cell ELISA was performed following a previously described protocol, with minor
modifications.30, 41 Briefly, E. faecium TX82 and its derivatives were grown in either BHI
or TSBG broth for 1, 6 or 16 h or on BHI plates overnight, with cultures containing pAT392
constructs supplemented with gentamicin. Cells were collected from broth cultures by
centrifugation or scraped from agar plates into phosphate-buffered saline (PBS), pH 7.4, and
washed twice with PBS. High binding microtiter plate wells (4HBX; Thermo Scientific,
Wobum, MA) were then coated for 1h with 100 μl of cells resuspended in 50 mM
carbonate-bicarbonate buffer, pH 9.6, and adjusted to OD600nm = 0.5. EbpCfm expression
was detected using affinity-purified polyclonal rEbpC-specific antibodies, as described
previously.30 Purified pre-immune antibodies from the same animal were used as a negative
control. Antiserum against formalin-killed whole cells of the E. faecium strain TX16,
included as a positive control,63 confirmed equal coating of all TX82 constructs included in
these assays.
Flow cytometry was used for quantification of surface expression of EbpCfm. Bacteria were
grown in BHI (with gentamicin for pAT392) for 12 h from an initial OD600nm of 0.01 and
surface exposed EbpCfm was labeled using the anti-EbpCfm antibody and R-phycoerythrin
conjugated secondary antibody, as described previously.30 Samples were analyzed by
Coulter EPICSXL AB6064 flow cytometer (Beckman Coulter) and System II software.
Mutanolysin cell wall extracts and western blot
Cell wall anchored proteins were released by a mutanolysin treatment from cells of E.
faecium grown in BHI broth for 12 h (starting OD600nm ~0.01), as previously described.30
Five μg of concentrated mutanolysin extracts, with total protein concentrations estimated by
the bicinchoninic acid assay (Pierce, Rockford, IL), were analyzed by a western blot, using
the anti-EbpCfm antibody and horse radish peroxidase-labeled secondary antibody, as
described recently.30
Immunoelectron microscopy
E. faecium cells were grown in either BHI or TSBG broth for 12 h or on BHI or blood agar
plates overnight; cultures containing pAT392 constructs were supplemented with
gentamicin. Cells from broth cultures were harvested by centrifugation and from plates by
scraping, and washed with 0.1 M NaCl. Immunogold labeling was performed as described
previously,64 using anti-EbpCfm antibodies (1:100 dilution) or pre-immune antibodies
(1:100 dilution),30 followed by 12-nm gold-donkey anti-goat IgG (1:20 dilution) (Jackson
ImmunoResearch Laboratories, Inc., West Grove, PA). Samples were viewed in a Jeol 1400
transmission electron microscope.
Biofilm formation and primary adherence
An assay for detecting in vitro biofilm formation by E. faecium, after incubation for 24 h in
TSBG broth, was performed following a previously described method, using 96-well
polystyrene plates (Becton Dickinson, Franklin Lakes, NJ).14 For plasmid stability analysis,
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the total bacterial growth in wells of the biofilm assay plate was resuspended (instead of
staining the biofilm by crystal violet), serially diluted and plated on BHI plates. Single
colonies (94-96 colonies/assay) were then resuspended in BHI broth in 96-well plates and
replica-plated onto BHI plates with and without gentamicin to screen for plasmid loss. For
assessing primary attachment to a polystyrene surface, 5 mL of an overnight (16 h) culture
in TSB broth, supplemented with 0.5% glucose, was diluted to OD600 = 0.1 and added to
six-well plates (Becton Dickinson, Franklin Lakes, NJ), as described previously.14 After 2 h
incubation, wells were washed six times with PBS, fixed, gram-stained and counted
microscopically.14
Mouse UTI model
Protocols previously used in our laboratory were followed for the preparation of mice,
inoculum volumes, and all other stages of the mixed-infection competition experiment.33 To
prepare inocula for infection, BHI-grown 24 h-cultures of E. faecium TX82 and
TX82ΔebpABCfm were resuspended in 0.9% saline solution and the suspensions were mixed
in equal (1:1) or 1:10 (WT versus mutant) ratios based on their OD600nm readings; these
inocula were also plated for colony counts. At 48 h after infection, CFU counts were
enumerated from bladders and kidneys, as previously described.33 Because of prior
observations that chloramphenicol resistance is not always expressed by mutants,52, 65 the
ratio of TX82 and TX82ΔebpABCfm among the recovered bacterial colonies were
determined by hybridizing colony lysates with a 488 bp intergenic ebpB-ebpCfm 30 probe
under high-stringency conditions.60, 66 Pre-approved protocols and guidelines of the Animal
Welfare Committee of the University of Texas Health Science Center at Houston were
followed throughout this study.
Statistical analyses
Differences in biofilm and primary adherence values between TX82 and its ebpABCfm
deletion and complementation derivatives were evaluated by the Mann-Whitney test. The
percentages of the ΔebpABCfm mutant in the inoculum versus the percentages of the
ΔebpABCfm mutant in the kidneys and bladders of individual mice co-infected with TX82
and TX82ΔebpABCfm in the competition assay were analyzed for significance by the paired
t test. The mean virulence index of TX82ΔebpABCfm versus TX82 in the UTI model was
calculated using the following equation: Mean virulence index =Σ [(% TX82 in inoculum)/
(%ΔebpABCfm in inoculum)]/Σ[(% TX82 in kidneys or bladders%)/(ΔebpABCfm in kidneys
or bladders)].18, 36, 52
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Schematic representation of the deleted ebpABCfm locus of TX82 and transcriptional
analysis of its effect on bpsfm, the downstream class C sortase gene. (A) A genetic map of
the ebp-bpsfm region, showing the segment deleted from TX82ΔebpABCfm by allelic
replacement with a cat gene. The previously predicted transcriptional terminator in the
intergenic region between ebpCfm and bpsfm is indicated with a lollypop and the lengths of
the previously determined mRNA transcripts are marked by arrows above the ebp-bpsfm
region.30 Arrowheads indicate locations of each primer pair for RT-PCR (see panel B
below). (B) RT-PCR analysis of bps gene expression of WT TX82 and its isogenic
ebpABCfm deletion mutant. Gel on left, RT-PCR of total RNA (20 ng), isolated from mid-
exponential cells and treated with DNase; middle gel, control reaction of the same RNA
sample amplified without RT; gel on right, control reaction with genomic TX82 DNA as
template. An intragenic region of gyrase (gyrA) was included as an internal control. Lane
numbers correspond to the primer pairs shown in panel A. M, molecular weight marker.
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Figure 2.
Characterization of EbpCfm surface expression by TX82 and its ebpABCfm deletion and
complementation derivates. (A) Surface expression of EbpCfm in different growth stages
and growth media, using whole-cell ELISA. Cells were washed and adjusted to OD600nm =
0.5 before coating on wells. EbpCfm expression was detected using an affinity-purified anti-
EbpCfm antibody.30 Bars represent the means of absorbance at 590nm ± SD from four
independent assays, each performed in triplicate. (B) Flow cytometry analysis. Labeling by
the anti-EbpCfm antibody is shown for each strain and by a pre-immune antibody (PI)30 for
TX82, and indicated as log fluorescence intensity on the X-axis. Bacteria were analyzed
using side scatter as the threshold for detection. Each histogram represents 50,000 events of
bacterium-sized particles. (C) Western blot of mutanolysin extracts. Five μg of mutanolysin
cell wall extracts were electrophoresed and blotted onto the membrane and probed with
affinity-purified anti-EbpCfm antibodies or pre-immune antibodies. Lane 1, TX82; lane 2,
TX82ΔebpABCfm; lane 3, TX82ΔebpABCfm (pAT392); lane 4, TX82ΔebpABCfm
(pAT392∷ebpABCfm), lane 5, rec-EbpCfm.30
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Figure 3.
Immuno-EM analysis of pilus production by WT TX82 and its ebpABCfm deletion mutant
and complementation derivates. A, TX82 grown on BHI plate; B, higher magnification of
the pilus seen in panel A; C. TX82 grown in BHI broth, showing two cells possibly
connected by a pilus; D, TX82 grown in TSBG; E, TX82 grown on a blood agar plate; F to
I, Complemented ebpABCfm deletion mutant (TX82ΔebpABCfm (pAT392∷ebpABCfm))
grown in BHI broth. Note the pili apparently linking several cells in panel I; J,
TX82ΔebpABCfm grown in BHI broth; K, TX82ΔebpABCfm (pAT392) grown in BHI broth;
L, TX82 grown in BHI broth. Panels A to K were stained with affinity-purified EbpCfm-
specific antibodies and panel L with pre-immune antibodies.30 Scale bars 200 nm.
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Figure 4.
Comparison of biofilm formation of TX82 (WT) versus its ebpABCfm deletion and
complementation derivates. (A) Biofilm formation without added gentamicin. (B) Biofilm
formation with overnight inoculum grown in the presence of gentamicin, but cultures in
biofilm plate in its absence. (C) Biofilm growth with both inoculum and plate incubated in
the presence of gentamicin. Median OD570nm values and interquartile ranges, with the
minimum and maximum values marked by whiskers, represent combined data from at least
three independent assays and 3 48 wells for each construct. Statistical analyses were
performed by the Mann-Whitney test and p values are shown in the figure.
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Figure 5.
Effect of the ebpABCfm deletion on primary attachment to polystyrene. (A) Adherence of
cells grown without gentamicin. B. Adherence of cells grown with gentamicin. Median
values and interquartile ranges show data combined from four independent assays. Adhering
bacteria were counted microscopically from a total of 64 fields (each ~2900 μm2) for each
construct. Statistical analyses were performed by the Mann-Whitney test and p values are
shown in the figure.
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Figure 6.
Effect of deletion of ebpABCfm in a murine model of UTI, using a mixed inoculum. (A)
Percentage of bacteria recovered from kidneys. (B) Percentage of bacteria recovered from
bladders. Two independent experiments are shown in both panels. Exp. 1, mice infected
with equal CFUs of TX82 and TX82ΔebpABCfm (2.8 × 106 CFU/mouse); Exp. 2, mice
infected with 10-fold overdose of TX82ΔebpABCfm (2.2 × 107 CFU/mouse) versus TX82
(2.2 × 106 CFU/mouse). Horizontal bars represent the means of percentages of total bacteria
in kidneys and bladders Statistical analyses were performed by the paired t test and p values
are shown in the figure. Empty circles and empty triangles represent percentages of TX82
and TX82ΔebpABCfm in inocula, respectively, while solid circles and solid triangles
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represent percentages of TX82 and TX82ΔebpABCfm recovered from kidneys and bladders
48 h post infection, respectively.
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Table 1
Bacterial strains and plasmids used in this study
Strains/plasmids Relevant characteristics* Reference or source
Strains
 E. faecium
  TX82 Endocarditis isolate. Vanr, Ampr 61
  TX5645 TX82ΔebpABCfm, ebpABCfm deletion mutant This study
  TX5664 TX5645 (pAT392), deletion mutant with empty complementation vector. Genr This study
  TX5665 TX5645 (pAT392∷ebpABCfm), deletion mutant complemented with ebpABCfm. Genr This study
  TX5667 TX82 (pAT392), WT with empty complementation vector. Genr This study
  TX5668 TX82 (pAT392∷ebpABCfm), WT supplemented with ebpABCfm. Genr This study
  TX2154 E1162, blood isolate. Ampr 27
  TX2155 E1162Δesp, deletion mutant. Ampr, Chlr 27
 E. coli
  DH5α E. coli cloning host Invitrogen
  XL1 Blue E. coli cloning host, Tetr Stratagene
  TX5644 DH5α (pTEX5644) This study
  TX5666 XL1 Blue (pAT392∷ebpABCfm) This study
 Plasmids
  pTEX5501ts Temperature sensitive plasmid, used for deletion mutagenesis of E. faecium. Chlr, Genr 61
  pTEX5644 Plasmid for ebpABCfm deletion; flanking regions of ebpABCfm cloned into pTEX5501ts. Chlr, Genr This study
  pAT392 Complementation vector. Genr 62
  pTEX5665 pAT392∷ebpABCfm; plasmid for complementation of the ebpABCfm mutant. Genr This study
*
Van, vancomycin; Amp, ampicillin; Gen, gentamicin; Tet, tetracycline; Chl, chloramphenicol; superscript “s” designates sensitivity, “r”
designates resistance.
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